A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This vital malignant suppressor protein is frequently lost in many types of malignancies, leading uncontrolled https://livebookmarking.com/story21948477/mini-antibodies-revive-tumor-suppressor-p53-the-potential-pathway-for-tumor-therapy